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Abstract
Background: Thromboxane A2 (TxA2)-induced smooth muscle contraction has been implicated in cardiovascular, renal and
respiratory diseases. This contraction can be partly attributed to TxA2-induced Ca
2+ influx, which resulted in vascular
contraction via Ca
2+-calmodulin-MLCK pathway. This study aims to identify the channels that mediate TxA2-induced Ca
2+
influx in vascular smooth muscle cells.
Methodology/Principal Findings: Application of U-46619, a thromboxane A2 mimic, resulted in a constriction in
endothelium-denuded small mesenteric artery segments. The constriction relies on the presence of extracellular Ca
2+,
because removal of extracellular Ca
2+ abolished the constriction. This constriction was partially inhibited by an L-type Ca
2+
channel inhibitor nifedipine (0.5–1 mM). The remaining component was inhibited by L-cis-diltiazem, a selective inhibitor for
CNG channels, in a dose-dependent manner. Another CNG channel blocker LY83583 [6-(phenylamino)-5,8-quinolinedione]
had similar effect. In the primary cultured smooth muscle cells derived from rat aorta, application of U46619 (100 nM)
induced a rise in cytosolic Ca
2+ ([Ca
2+]i), which was inhibited by L-cis-diltiazem. Immunoblot experiments confirmed the
presence of CNGA2 protein in vascular smooth muscle cells.
Conclusions/Significance: These data suggest a functional role of CNG channels in U-46619-induced Ca
2+ influx and
contraction of smooth muscle cells.
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Introduction
Thromboxane A2 (TxA2) is an unstable prostanoid produced
predominantly in platelets from prostaglandin H2 by thrombox-
ane-A synthase. Functionally, TxA2 acts on the TP receptor (TxA2
receptor) to promote platelet aggregation [1] and to induce
smooth-muscle contraction [2,3]. Two main mechanisms underlie
the TxA2-induced contraction of vascular smooth muscle. The first
mechanism is the Ca
2+ sensitization of contraction, which refers to
a sensitized contractile response to a small rise in [Ca
2+]i [4]. This
mechanism has been extensively studied in recent years. It is clear
that the Ca
2+ sensitization can be attributed to a reduced activity
of myosin light-chain phosphatase, followed by a greater degree of
phosphorylation of myosin light chain 20, leading to the sensitized
contractile response to Ca
2+ [5]. The second mechanism is related
to TxA2-elicited increase in [Ca
2+]i, which enhances the smooth
muscle cell contraction via Ca
2+-calmodulin-myosin light-chain
kinase pathway. Relatively little is known about the detailed
mechanism of how TxA2 elicits a [Ca
2+]i rise. Tosun et al. found
that both L-type and non-L-type Ca
2+ influx channels could
account for thromboxane A2 receptor-mediated contraction in rat
aorta, but the identity of the non-L-type calcium channel is
unclear (1998). Evidence also shows that the Ca
2+ sensitization
process also requires Ca
2+ influx, because removal of extracellular
Ca
2+ abolished the Ca
2+ sensitization [2,6].
Cyclic nucleotide-gated (CNG) channels are Ca
2+-permeable
nonselective cation channels. Six CNG isoforms have been
identified, these includes four A subunits and two B subunits.
CNGA1–A3 subunits may form functional channels on their own,
while B and A4 subunits serve modulatory functions. In native
cells, CNG channels usually form heterotetrameric complexes
consisting of A and B subunits [7]. CNG channels are widely
expressed in vascular tissues across species and vascular beds [8,9].
Specifically, CNGA1 was found to be abundantly expressed in the
endothelium layer, and also expressed in vascular smooth muscle
layers but at a much lower level in guinea pig arteries [9]. In
contrast, strong expression of CNGA2 channel was detected in
both the endothelium and smooth muscle layers of human arteries
[8]. Functionally, endothelial cell CNG channels play an
important role in endothelium-dependent vascular dilation to a
number of cAMP-elevating agents including adenosine, adrenaline
and ATP [10,11,12]. However, up to the present, there is still no
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cells.
In the present study, we tested the hypothesis that CNG
channels may contribute to TxA2-induced Ca
2+ influx and
contraction in vascular smooth muscle cells. A stable TxA2
analogue U-46619 was used to induce contraction in the
endothelium-denuded small mesenteric artery segments. This
constriction was inhibited by L-cis-diltiazem and LY83583, two
selective inhibitors for CNG channels, in dose-dependent manner.
Immunoblot experiments found the expression of CNGA2
proteins in the primary cultured vascular smooth muscle cells.
These data suggest a functional role of CNG channels in U-46619-
induced Ca
2+ influx smooth muscle contraction.
Results
Because TxA2 is an unstable compound, we used a stable TxA2
analogue U-46619 (100 nM) to induce contraction in isolated rat
small mesenteric artery segments (Figure 1A). To limit the study to
vascular smooth muscle cells, the endothelial layer was rubbed off
with wire before all contraction studies. U-46619-induced vascular
contraction in these artery segments depended upon Ca
2+ influx,
because U-46619 failed to induce contraction after chelation of
extracellular Ca
2+ with 1 mM BAPTA (Figure 1A). We next
explored the identity of the Ca
2+-permeable channels. In the
vessels that were pre-contracted with U-46619 (100 nM), an L-
type Ca
2+ channel inhibitor nifedipine relaxed the vessels
(Figure 1B), suggesting an involvement of L-type Ca
2+ channels
in U-46619-induced smooth muscle contraction.
We next explored other Ca
2+-permeable channels involved. In
order to better resolve the component that was independent of L-
type Ca
2+ channels, arterial segments were first treated with
nifedipine (1 mM) to inhibit L-type Ca
2+ channels (Figure 1C). In
our preparation, 1 mM nifedipine was sufficient for complete
inhibition of L-type Ca
2+ channels, because it could almost fully
reverse the high K
+ (60 mM)-induced contraction (Figure 2A).
High concentration of K
+ in extracellular bath causes membrane
depolarization, which open voltage-gated L-type Ca
2+ channels,
resulting in vascular contraction [13]. After the inhibition of L-
type Ca
2+ channels with nifedipine, subsequent addition of U-
46619 could still induce contraction (Figure 1C, Figure 2A). Again,
the U-46619-induced contraction required Ca
2+ influx, because it
was reversed by removal of extracellular Ca
2+ (Figure 1C inset) or
addition of EGTA in the bath (Figure 1C). We next explored the
possible involvement of CNG channels. As shown in Figure 2A,
cumulative addition of L-cis-diltiazem (5–200 mM) caused a
Figure 1. Representative traces of the tension developed in endothelium-denuded small mesenteric arteries. A. Addition of 1 mM
BAPTA in Ca
2+-free KHS prevented the U46619-induced contraction. B. Nifedipine significantly inhibited the U46619-induced contraction. C.1mM
nifedipine was added to block the contraction induced by high K
+ solution. After stabilization, U46619 was added to recontract the vessel, followed
by the addition of 3 mM EGTA. Inset of C. similar to C, except that the U46619-induced contraction was followed by replacing the bath solution by a
Ca
2+-free KHS. n=5.
doi:10.1371/journal.pone.0011098.g001
TxA2 and CNG Channels
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e11098concentration-dependent inhibition of U-46619-induced contrac-
tion. D-cis-diltiazem had similar inhibitory effect on the contrac-
tion, though its effect was less potent than that of L-cis-diltiazem
(Figure 2B). L-cis-Diltiazem is a highly selective inhibitor of CNG
channels. It blocks all three functional types of CNG channels,
including rod-type CNGA1, olfactory-type CNGA2 and cone-type
CNGA3, at micromolar concentration [14,15]. The drug exerts its
effect from the cytoplasmic face of the channel; extracellular
application is less effective [16,17]. D-cis-diltiazem is the
enantiomer of L-cis-diltiazem. D-cis-diltiazem is a well-known
blocker of L-type Ca
2+ channels. Both L-cis-diltiazem and D-cis-
diltiazem are membrane-permeable [14,15]. In our experiments,
L-type Ca
2+ channels were first blocked by sufficient concentration
of nifedipine, thus the effect of L-cis-diltiazem and D-cis-diltiazem
on the U-46619-induced contraction could not be attributed to L-
type Ca
2+ channels. As a precaution, we also tested the effect of
nicardipine, which is another potent blocker of L-type Ca
2+
channel (Figure 2C). Previously, it was shown that nicardipine at
1 nM could completely inhibit L-type Ca
2+ channels [18]. In the
present study, nicardipine up to 10 nM had no effect on the U-
46619-induced contraction. These results confirm that the
observed effect of L-cis-diltiazem was due to its action on CNG
channels but not on L-type Ca
2+ channels. We also tested another
CNG channel blocker LY-83583 [19]. This agent also caused
dose-dependent inhibition on U-46619-induced contraction
(Figure 3).
U-46619-induced Ca
2+ influx was studied in the primary
cultured rat vascular smooth muscle cells. In these studies, the
Figure 2. Effect of L-cis-diltiazem on the contraction induced by U46619. A. A representative trace of the tension developed in an
endothelium-denuded small mesenteric artery. 1 mM Nifedipine was added to inhibit L-type Ca
2+ channels. U46619 (100 nM) was added to recontract
the vessel, which is followed by cumulative doses of L-cis-diltiazem. N=5. B. A dose response curve showing the concentration dependent effect of L-
and D-cis-diltiazem on contractions induced by U46619 after the blockage of L-type voltage-gated Ca
2+ channels. Mean 6 SE (n=5). C.A
representative trace of the tension developed in the ring showing that nicardipine had no additional effect on U-46619-induced contractions after
the blockage of L-type voltage-gated Ca
2+ channels by nifedipine. N=4.
doi:10.1371/journal.pone.0011098.g002
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Ca
2+ channels. This would allow us to better resolve the Ca
2+
influx pathway that is independent of L-type Ca
2+ channels. As
shown in Figure 4A,B, U-46619 still induced a cytosolic Ca
2+ rise
in these cells. L-cis-diltiazem (100 mM) inhibited this Ca
2+ rise,
supporting a role of CNG channels in this Ca
2+ rise.
Immunoblots were used to examine the CNG channel isoforms
that are expressed in vascular smooth muscle cells. Figure 5 shows
that an anti-CNGA2 and an anti-CNGA3 antibody recognized
respective proteins with expected molecular sizes, while the anti-
CNGA1 antibody failed to detect expression of CNGA1 in the
protein lysates prepared from rat aortic smooth muscles. Note that
multiple bands in the immunoblot of CNGA2 proteins might
represent the same proteins that were glycosylated at different
degree [20].
Discussion
TxA2 is implicated in many cardiovascular, renal and
respiratory diseases [21]. Much of these problems is associated
with TxA2-induced smooth muscle contraction, which leads to
vascular constriction, ischemia, pulmonary hypertension and
broncho-constriction [22,23]. In the present study, we explored
the mechanism of TxA2-induced vascular smooth muscle cell
contraction. Our results showed that, in the absence of
extracellular Ca
2+, U46619 failed to constrict the isolated small
mesenteric artery segments. In addition, removal of extracellular
Ca
2+ relaxed the artery segments that were preconstricted with U-
46619. Furthermore, inhibition of L-type Ca
2+ channels by
nifedipine reduced the contractile response to U-46619. These
data agree with the previous reports by others [2,3], and support
the notion that Ca
2+ influx is required for U46619-induced
vascular constriction and that L-type Ca
2+ channels play a role in
this constriction.
Because the inhibition of L-type Ca
2+ channels by nifedipine
only caused a partial inhibition of U46619-induced constriction,
we next explored the possible involvement of CNG channels in
U46619-induced constriction. In these experiments, arterial
segments were first treated with nifedipine to block L-type Ca
2+
channels in order to better resolve the component that was
independent of L-type Ca
2+ channels. Under this condition, U-
46619-induced contraction was found to be inhibited by L-cis-
diltiazem in a dose-dependent manner. L-cis-diltiazem also
inhibited U-46619-induced cytosolic Ca
2+ rise in the primary
cultured vascular smooth muscle cells. The inhibitory action of L-
cis-diltiazem suggests the involvement of CNG channels in U-
46619-induced Ca
2+ rise in smooth muscle cells and subsequent
vascular constriction. This hypothesis was supported by the
LY83583 experiments, in which LY83583 also caused a dose-
dependent inhibition of U-46619-induced vascular constriction.
LY-83583 is a less selective agent and it inhibits both CNG
channels and soluble guanylate cyclase at similar concentrations
[19]. However, we reason that the inhibitory action of LY-83583
on U-46619-induced vascular constriction should be due to CNG
channels but not to soluble guanylate cyclase, because an
inhibition of soluble guanylate cyclase would result in contraction
instead of the observed relaxation (Figure 5).
CNG channels are widely expressed in different vascular tissues
including cerebral and coronary arteries [8,9,24,25]. There are
three functional subunits CNGA1-A3. All these three subunits
were reported to be expressed both in vascular endothelial cells
and vascular smooth muscle cells [8,9,24–26]. Previous study also
Figure 3. Effect of LY83583 on U-46619-induced vasoconstriction in an endothelium-denuded small mesenteric artery segment. A.
A representative trace of the tension developed in the ring upon various treatments. B. A dose response curve showing the concentration dependent
effect of LY83583 on contractions induced by U-46619 in the presence of L-type voltage-gated Ca
2+ channels blocker. Mean 6 SE (n=4).
doi:10.1371/journal.pone.0011098.g003
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very low, because RT-PCR could detect CNGA1 in cultured
vascular smooth muscle cells but Western blot and in situ
hybridization failed to detect CNGA1 in vascular tissues [9,24].
In the present study, we found the expression of CNGA2 and A3,
but not A1, in the protein lysates from rat vascular smooth muscle
cell layers. These data are consistent with the previous reports, and
suggest that CNGA2 or A3, but not CNGA1, are more likely to be
involved in the U-46619-induced vascular constriction. Note that
unlike other CNG isoforms [16] which are insensitive to D-cis-
diltiazem even at mM concentration, olfactory-type CNGA2 is
inhibited by D-cis-diltiazem though with much less potency
compared to that of L-cis-diltiazem. In our experiments, high
concentration of D-cis-diltiazem inhibited U-46619-induced vas-
cular constriction with the dose-response curve mirrors that of
olfactory-type CNGA2 reported by Frings et. al. [15]. These data
suggest olfactory-type CNGA2 to be a more likely candidate that is
involved in the U-46619-induced vascular constriction.
In conclusion, TxA2-induced vascular contraction was inhibited
by two CNG channel inhibitors L-cis-dialtiazem and LY-83583.
Our data suggest that CNG channels, olfactory-type CNGA2 in
particular, contribute to TxA2-induced Ca
2+ influx in vascular
smooth muscle cells.
Materials and Methods
Ethics statement
The animal study was conducted in conformity with the Guide for
Animal Care and Use of Laboratory Animals published by the US
National Institute of Health. The experiments were approved by
the Department of Health of Hong Kong and carried out by
investigators licensed (06-3indh/orhi/821pt.5) under section 7 of
the Animals (Control of Experiments) Ordinance (Cap. 340).
Blood vessel preparation
Mesenteries with supplying blood vessels removed from adult
Sprague Dawley rats (250 g–300 g) killed by carbon dioxide
overdose were placed into Krebs-Henseleit solution (KHS) (in
mM): 118 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgSO4, 25.2 NaHCO3,
1.2 KH2PO4, and 11.1 D-glucose. Second order small mesenteric
artery ring segments of about 3 mm in length were isolated and
cleared of adhering fatty tissues. Each segment was mounted in the
tissue chamber of a Multi Myograph System (Danish Myo
Technology, Aarbus, Denmark) with two wires passing through
the lumen. The tissue chambers contained KHS that was
constantly bubbled with 95% O2 plus 5% CO2 and maintained
at 37uC throughout the duration of the experiment. Endothelium
was removed mechanically by gently rubbing the luminal surface
with a piece of stainless steel wire. Each ring was stretched to an
initial tension of 1 mN and the changes in tension were recorded
in a myograph. The rings were precontracted twice in 60 mM K
+
KHS and then contracted with 2 mM phenylephrine, followed by
1 mM acetylcholine to ascertain the completeness of endothelium
removal. Only those with less then 5% relaxation were considered
as endothelium denuded. The rings were then washed three times
in normal KHS.
Measurement of isometric force
To study if Ca
2+ influx is required for U46619-induced
contraction, 100 nM U-46619 was added to initiate contraction
in the rings. After that, the rings were washed three times with
Ca
2+-free KHS and incubated in 1 mM BAPTA before the rings
were recontracted with the same concentration of U-46619. In
some experiments, EGTA (3 mM) was added or extracellular Ca
2+
was removed after the U-46619-induced tension became stable
(n=4).
To assess the effect of L-cis-diltiazem on U-46619-induced
contraction, the bathing solution was changed to 60 mM K
+
solution to open the voltage-gated Ca
2+ channels, followed by an
addition of 1 mM nifedipine to block L-type voltage-gated Ca
2+
channels. After the tone returned to basal level, which is an
indication that most, if not all, of the voltage-gated channels were
blocked, the vessels were recontracted with 100 nM U-46619.
Cumulative doses (from 20 mM to 200 mM) of L-cis-diltiazem, a
specific CNG channel blocker, were added to assess the role of
CNG channels in the contraction. The concentration-dependent
relaxant effect of D-cis-diltiazem was also examined for compar-
ison. A control experiment running in parallel without the addition
Figure 4. Effect of U46619 and L-cis-diltiazem on [Ca
2+]i in the
primary cultured aortic smooth muscle cells. Cells were
pretreated with 300 nM nifedipine to block L-type Ca
2+ channels. A,
B. Representative fluorescence images of cultured smooth muscle cells
before (A) and after (B) 100 nM U46619. C. Summary of data showing
the inhibitory effect of L-cis-diltiazem (100 nM) on U46619-induced
[Ca
2+]i rises. Shown were the percentage of cells displaying U46619-
induced [Ca
2+]i rises before and after U46619 challenge, Mean 6 SE
(n=5). * p,0.05 as compared with the control.
doi:10.1371/journal.pone.0011098.g004
Figure 5. Western blotting showing the expression of CNGA2
and CNGA3 proteins in rat aortic smooth muscle cells. Shown
were representative images from 3 independent experiments.
doi:10.1371/journal.pone.0011098.g005
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sustained during the experimental time period.
Cell culture
The primary cultured rat aortic smooth muscle cells were
isolated from SD rat aorta as described elsewhere [27]. Briefly, the
adherent adventitia layer was peeled off before the aorta was cut
into small pieces and digested with 0.1% collagenase in Ca
2+-free
PSS (in mM: 55 NaCl, 80 sodium glutamate, 5.6 KCl, 10 HEPES,
2 MgCl2, 10 glucose, pH 7.4) for 25 min at 37uC under vigorous
shaking. The tissues were then rinsed several times in PSS to
remove the collagenase. Smooth muscle cells were dissociated
from the tissues by pipetting up and down using a Pasteur pipet.
The cells were seeded on coverslip and grown in 80% DMEM and
20% FBS with 1% antibiotic-antimicotic for a week before Ca
2+
-imaging experiments.
[Ca
2+]i measurement
Cultured cells were loaded with 10 mM Fluo-4/AM for 20 min
in dark at 37uC in culture medium. Then the cells were briefly
washed and bathed in a normal physiological saline solution
(NPSS) that contained in mM: 140 NaCl, 5 KCl, 1CaCl2,1 0
glucose, 5 Hepes, pH 7.4. The experimental chambers were
placed on the stage of an inverted microscope (Olympus IX81).
Fluorescence was measured using the FV1000 laser scanning
confocal imaging system. The excitation wavelength was at
488 nm and the fluorescence signals were collected using a
515 nm long pass emission filter. Data analysis was performed
with FV1000 software. Changes in [Ca
2+]i were displayed as a
ratio of fluorescence relative to the fluorescence before the
application of U-46619.
Western blotting analysis
Thoracic aorta was isolated from Sprague Dawley rats (250–
300 g) and placedin PBS immediately.The surrounding connective
tissue was carefully trimmed off and endothelial cells removed by
rubbing with a piece of cotton. The aorta was then homogenized in
lysis buffer containing 50 mM Tris–base, 150 mM NaCl, 50 mM
NaF, 1% Nonidet P-40, 0.5% sodium deoxycholate, pH 7.5, with
addition of the protease inhibitor cocktail tablets (Roche) and
centrifuged at 10,000 g for 5 min at 4uC. The supernatant was
collected, and the protein concentration was quantified using
Bradford reagent (BioRad, Hercules, CA). Samples (50 g protein/
lane)weresubjected toSDS-polyacrylamidegelelectrophoresis,and
transferred to polyvinylidene difluoride membrane. Antibodies
against CNGA1 (1:200, Santa Cruz) or CNGA2 (1:1000,
polyclonal, directed against residues 559–664 of CNGA2) or
CNGA3 (1:200, Alamone lab) were incubated with the membrane
overnight at 4uC. The anti-CNGA2 polyclonal antibody was self-
raised following a previous published protocol [20]. Immunolabeled
membranes were subjected to probing with horseradish peroxidase-
linked secondary antibodies, and visualized by chemiluminescence
using ECL kit (GE Healthcare, Little Chalfont, Buckinghamshire,
UK).
Materials
Chemicals. Acetylcholine, nifedipine, ethylene glycol tetraacetic
acid (EGTA), 1,2-bis(o-aminophenoxy) ethane-N,N,N’,N’-tetraacetic
acid (BAPTA) and D-cis-diltiazem were purchased from Sigma
Aldrich, L-cis-diltiazem from Biomol International and U-46619
from Calbiochem. U-46619, BAPTA and nifedipine were dissolved
in DMSO and others in distilled water.
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